HM Payson & Co’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-46
Closed -$11K 1096
2021
Q4
$11K Buy
+46
New +$11.2K ﹤0.01% 851
2021
Q2
Sell
-222
Closed -$46K 1126
2021
Q1
$46K Sell
222
-39
-15% -$8.29K ﹤0.01% 618
2020
Q4
$49K Sell
261
-66
-20% -$10.8K ﹤0.01% 609
2020
Q3
$42K Buy
+327
New +$36K ﹤0.01% 592

Other funds holding INSP

HM Payson & Co's INSP Position: Q1 2022 in Review

HM Payson & Co sold out of Inspire Medical Systems (INSP) in Q1 2022, closing a stake of 46 shares — an estimated $11K sold.

HM Payson & Co first reported a position in INSP in Q3 2020 and held it in 4 quarters. The position peaked at $49K in Q4 2020. 298 funds tracked by Wall St. Rank hold INSP as of Q1 2022.

  • HM Payson & Co reported no remaining Inspire Medical Systems position as of Q1 2022 after selling out during the quarter.
  • HM Payson & Co sold 46 Inspire Medical Systems shares in Q1 2022, an estimated $11K.
  • HM Payson & Co first reported a position in Inspire Medical Systems in Q3 2020 and held it in 4 quarters.
  • HM Payson & Co's Inspire Medical Systems position peaked at $49K in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2022.

Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.